dihydrotestosterone (androstanolone) in serum/plasma

Indications

• monitoring 5-alpha-reductase inhibitor therapy for benign prostatic hypertrophy
• evaluating possible 5-alpha-reductase deficiency

Reference interval

Adult Male >19 years: 112-955 pg/mL Adult Female 20-55 years: < 300 pg/mL Adult Female >55 years: < 128 pg/mL

Methods

• Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

More general terms

• dihydrotestosterone (androstanolone) in body fluid

More specific terms

• dihydrotestosterone (androstanolone) free in serum/plasma
• dihydrotestosterone (androstanolone) in serum/plasma post challenge

Additional terms

• stanolone; dihydrotestosterone (DHT); androstanolone; 5-alpha androstan-17-beta-ol-3-one